Sources and small print
** Results are based on the STEP 1 Wegovy trial. Results vary – weight loss can be more or less than the 15% average.
Wilding, J.P.H. et al. (2021) "Once-weekly semaglutide in adults with overweight or obesity" New England Journal of Medicine, 384(11)
https://doi.org/10.1056/NEJMoa2032183
*** An admin fee may apply for early cancellation. See our terms and conditions.
